// App-Quantinova.ai

1504 : Pulmonary Hypertension (PHT) and Pleural Effusion During Dasatinib Therapy For CML Frequently Lead To Drug Withdrawal

Researchers

Presenter

  • Maciek Tatarczuch

Principal Investigators

  • John F Seymour

  • Louise Creati

  • Elchanan H. Januszewicz

  • Kate Burbury

Medical Centers

  • Dept. of Hematology, Peter MacCallum Cancer Center, Melbourne, Australia

  • Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia

  • Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Acute Coronary Syndromes

  • Pulmonary arterial hypertension

  • Acute myelocytic leukemia

  • Opioid withdrawal syndrome

  • Hypertension

  • Sepsis

Biomarkers

  • Cluster of Differentiation 206

Drug/Treatment

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved